Safety, tolerability, and efficacy of NLY01 in early untreated Parkinsons disease: a randomised, double-blind, placebo-controlled trial
By combining diagnostics, medication when appropriate, and proven behavior change, we help your body work better from the inside out. Nooms Chief Medical Officer FAQ Read more about weight-loss medications Our clinical team offers a wide array of medications to give the best treatment to those who qualify.
Patients interested in cognitive performance support or those navigating post-concussion recovery have increasingly requested this formula as part of a broader care plan
PubMed One real-world study showed that patients with type 2 diabetes using GLP-1 RAs had a reduced risk of incident dementia compared with some other second-line diabetes therapies
I want to have an honest conversation with you about something that has been transforming how we approach medicine here at AgeRejuvenation, and that is peptide therapy
Rising global prevalence of obesity and type 2 diabetes is a primary growth driver for the market